medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2004, Number 1

<< Back

Ann Hepatol 2004; 3 (1)

Symptomatic focal nodular hyperplasia during pregnancy: A case report

Byrnes V, Cárdenas A, Afdha N, Hanto D

Language: English
References: 24
Page: 35-37
PDF size: 73.85 Kb.


Text Extraction

A 30-year-old woman presented with hepatomegaly and an audible hepatic bruit at 24 weeks gestation. Non-contrast MRI demonstrated an exophytic 12.6 x 7.8 x 12.8 cm mass arising from the right lobe of the liver with a central scar, suggestive of focal nodular hyperplasia (FNH). Conservative management included monthly abdominal ultrasound examinations until the time of delivery, to assess growth of the mass and monitor for risk of rupture. Seven weeks post partum the patient experienced severe right upper quadrant pain. A CT angiogram of the liver demonstrated a stable mass with no evidence of bleed or rupture and multiple hypervascular masses throughout the liver. Surgical resection of the dominant lesion was performed. Histological examination of the lesion confirmed FNH. The patient is now 22 months post surgery with radiographic evidence of stable multifocal FNH.


REFERENCES

  1. Craig, J, Peters, R, Edmundson H. Tumors of the Liver and Intrahepatic Bile Ducts, Fasc 26, 2nd ed. Washington, DC Armed Forces Institute of Pathology, Washington DC 1989 p. 6.

  2. Wanless, IR, Mawdsley C, Adams R. On the Pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5: 1194-200.

  3. Fukukura Y, Nakashima O, Kusaba A, et al. Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. J Hepatol 1998; 29: 470-5.

  4. Kondo F, Nagao T, Sato T, et al. Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract 1998; 194: 487-95.

  5. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 1986; 110: 331-5.

  6. Nakanuma Y. Non-neoplastic Nodular Lesions in the Liver. Pathol Int 1995; 45: 703-14

  7. Nime F, Pickren JW, Vana J, et al. The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer 1979; 44: 1481-9.

  8. Aldinger K, Ben-Menachern Y, Whalen G. Focal Nodular Hyperplasia of the Liver Associated with High Dose Estrogens. Arch Intern Med 1977; 137: 357-9.

  9. Klatskin G. Hepatic Tumors: Possible Relationship to Use of Oral Contraceptives. Gastroenterology 1977; 73: 386-94.

  10. Shortell CK, Schwartz SI. Hepatic adenoma and focal nodular hyperplasia. 1991; 173: 426-31.

  11. Van Hoe L, Baert AL, Gryspeerdt S, et al. Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions. AJR Am J Roentgenol 1997; 168: 1185-92.

  12. Brady MS, Coit DG. Focal nodular hyperplasia of the liver. Surg Gynecol Obstet 1990; 171: 377-81.

  13. Mathieu D, Bruneton JN, Drouillard J, et al. Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 1986; 160(1): 53-8.

  14. Ishak KG, Rabin L. Benign Tumors of the Liver. Med Clin North Am 1975; 59: 995-1013.

  15. Weimann A, Ringe B, Klempnauer J, et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997; 21: 983-91.

  16. Nguyen BN, Flejou JF, Terris B, et al. Focal nodular hyperplasia of the liver: A comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999; 23: 1441-54.

  17. Wanless IR. Nodular regenerative hyperplasia, dysplasia, and hepatocellular carcinoma. Am J Gastroenterol 1996; 91: 836-7.

  18. Mathieu D, Kobeiter H, Maison P, et al. Oral Contraceptive Use and Focal Nodular Hyperplasia of the Liver. Gastroenterology 2000; 118: 560-4.

  19. Weimann A, Ringe B, Klempnauer J, et al. Benign Liver Tumors: Differential Diagnosis and Indications for Surgery. World J Surg 1997; 21: 983.

  20. Heinemann LA, Weimann A, Gerken G, et al. Modern oral contraceptive use and benign liver tumors: The German Benign Liver Tumor Case-Control Study. Eur J Contracept Reprod Health Care 1998; 3: 194-200.

  21. Di Stasi M, Caturelli E, Di Sio I, et al. Natural history of focal nodular hyperplasia of the liver: An ultrasound study. J Clin Ultrasound 1996; 24: 345-50.

  22. Leconte I, Van Beers BE, Lacrosse M, et al. Focal nodular hyperplasia: Natural course observed with CT and MRI. J Comput Assist Tomogr 2000; 24: 61-6.

  23. Weimann A, Mössinger M, Fronhoff K, et al. Pregnancy in Women with Observed Focal Nodular Hyperplasia of the Liver. Lancet 1998; 351: 1251-2.

  24. Buetow PC, Pantongrag-Brown L, et al. Focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Radiographics 1996; 16: 369-88.




2020     |     www.medigraphic.com